C. Frimat

Mutation analysis of TET2, IDH1, IDH2 and ASXL1 in chronic myeloid leukemia

C. Preudhomme, P. Rousselot, F. Mahon, 2011, Leukemia.

Molecular prognostic factors in acute myeloid leukemia receiving first-line therapy with azacitidine

B. Quesnel, A. Duhamel, C. Preudhomme, 2016, Leukemia.

Molecular Prognostic Factors in Acute Myeloid Leukemia (AML) Patients Receiving First Line Therapy with Azacytidine (AZA)

B. Quesnel, C. Preudhomme, P. Fenaux, 2014 .

Comprehensive molecular landscape in patients older than 80 years old diagnosed with acute myeloid leukemia: A study of the French Hauts‐de‐France AML observatory

B. Quesnel, C. Preudhomme, C. Berthon, 2018, American journal of hematology.